Revaluing ablation therapy: History, recent developments, and future Heart Rhythm Society strategy

Authors

Christopher F. Liu, Weill Cornell Medical College, New York, New York.
Andrew D. Krahn, University of British Columbia, Vancouver, British Columbia.
Fred Kusumoto, Mayo Clinic Jacksonville, Jacksonville, Florida.
Kimberly A. Selzman, George E. Wahlen Veteran's Affairs Hospital, Salt Lake City, Utah.
Amit J. Shanker, Rochester Regional HealthFollow
Emily P. Zeitler, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.
Daniel P. Morin, Ochsner Medical Center, New Orleans, Louisiana.

Department

Cardiology

Document Type

Article

Publication Title

Heart Rhythm

First Page

1566

Last Page

1568

DOI

10.1016/j.hrthm.2022.07.015

Volume

19

Issue

9

Publication Date

9-1-2022

Medical Subject Headings

Atrial Fibrillation (surgery); Catheter Ablation; Humans; Tachycardia, Supraventricular (surgery)

PubMed ID

35868520

Recommended Citation

Liu, C. F., Krahn, A. D., Kusumoto, F., Selzman, K. A., Shanker, A. J., Zeitler, E. P., & Morin, D. P. (2022). Revaluing ablation therapy: History, recent developments, and future Heart Rhythm Society strategy. Heart Rhythm, 19 (9), 1566-1568. https://doi.org/10.1016/j.hrthm.2022.07.015